跳至主要内容
临床试验/CTRI/2024/05/067829
CTRI/2024/05/067829尚未招募2 期

Efficacy Of Individualized Homoeopathic Medicines In The Management Of Non Alcoholic Fatty Liver Disease: A Prospective Randomized Single Blind Placebo Controlled Trial - NI

Government of Uttar Pradesh0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Individuals with Grade I to III NAFLD established by Ultrasonography and or ALT enzymes level more than 30 IU per mL in males and more than 19 IU per mL in females
  • Clinically diagnosed cases of Fatty Liver
  • Patients willing to give consent either

排除标准

  • Pregnant females and lactating mothers will be excluded
  • Individuals not providing written informed consent for the study
  • Patient with existing from liver diseases like Alcoholic Fatty Liver Grade IV Non Alcoholic fatty Liver disease viral hepatitis Autoimmune liver diseases hepatocellular carcinoma
  • Patient with Uncontrolled Diabetes Uncontrolled Hypertension renal or cardiac disease stroke or any other serious systemic illness
  • Patient on any other medication
  • Patient with medical emergencies

研究者

发起方
Government of Uttar Pradesh

相似试验